Sign in
4

Changes in Ownership

Twist Bioscience Corp Filed Acc 0001214659-26-010403

Chief Executive Officer sold 19,952 shares at $125.08 ($2,495,508)

  • Chief Executive Officer acquired 19,952 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Leproust Emily M. · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-12 Exercise or conversion : show line 1 in the form 10b5-1 +19,952 $26.66 $531,920 838,890 D
2026-08-12 Sale : show line 2 in the form 10b5-1 −19,952 $125.08 $2,495,508 818,938 D
Open-market sales · 19,952 sh · avg $125.08 · $2,495,508

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-12 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (right to buy) −19,952 133,269 D
Loading xslF345X06/marketforms-73765.xml…